Literature DB >> 8712128

The results of atrial flutter ablation in patients with and without a history of atrial fibrillation.

C Movsowitz1, D J Callans, D Schwartzman, C Gottlieb, F E Marchlinski.   

Abstract

To determine the impact of atrial flutter radiofrequency catheter ablation on recurrence of atrial flutter and atrial fibrillation, 32 patients with atrial flutter (18 with a history of atrial fibrillation) were followed for a mean of 8.6 months; atrial flutter has not recurred after 1 (26 patients) or 2 (5 patients) successful ablation procedures. Atrial flutter did not appear proarrhythmic for atrial fibrillation, with only 1 of 15 patients without a history of atrial fibrillation developing the arrythmia in the absence of an alcohol binge or cocaine use.

Entities:  

Mesh：

Year:  1996        PMID： 8712128     DOI： 10.1016/s0002-9149(96)00233-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  10 in total

1.  Quality of life and occurrence of atrial fibrillation in long-term follow-up of common type atrial flutter ablation: ablation with irrigated 5 mm tip and conventional 8 mm tip electrodes.

Authors:  Axel Meissner; Martin Christ; Petra Maagh; Rolf Borchard; Marc van Bracht; Ingo Wickenbrock; Hans-Joachim Trappe; Gunnar Plehn
Journal:  Clin Res Cardiol       Date:  2007-08-31       Impact factor: 5.460

Review 2.  Approaching a decade of cryo catheter ablation for type 1 atrial flutter-a meta-analysis and systematic review.

Authors:  Peter Andrew; Yasir Hamad; Sandra Jerat; Annibale Montenero; Stephen O'Connor
Journal:  J Interv Card Electrophysiol       Date:  2011-06-11       Impact factor: 1.900

3.  Catheter ablation of inducible atrial flutter, in combination with atrial pacing and antiarrhythmic drugs ("hybrid therapy") improves rhythm control in patients with refractory atrial fibrillation.

Authors:  Atul Prakash; Sanjeev Saksena; Ryszard B Krol; Artur Filipecki; George Philip
Journal:  J Interv Card Electrophysiol       Date:  2002-06       Impact factor: 1.900

4.  Early versus late atrial fibrillation after atrial flutter ablation.

Authors:  Emmanuel Loutrianakis; Tawfik Barakat; Brian Olshansky
Journal:  J Interv Card Electrophysiol       Date:  2002-06       Impact factor: 1.900

5.  Symptomatic improvement after radiofrequency catheter ablation for typical atrial flutter.

Authors:  P A O'Callaghan; M Meara; E Kongsgaard; J Poloniecki; L Luddington; J Foran; A J Camm; E Rowland; D E Ward
Journal:  Heart       Date:  2001-08       Impact factor: 5.994

6.  Nearly uniform failure of atrial flutter ablation and continuation of antiarrhythmic agents (hybrid therapy) for the long-term control of atrial fibrillation.

Authors:  Nicholas Anastasio; David S Frankel; Marc W Deyell; Erica Zado; Edward P Gerstenfeld; Sanjay Dixit; Joshua Cooper; David Lin; Francis E Marchlinski; David J Callans
Journal:  J Interv Card Electrophysiol       Date:  2012-05-04       Impact factor: 1.900

Review 7.  [Radiofrequency catheter ablation of atrial flutter and atrial fibrillation].

Authors:  C Reithmann; E Hoffmann; G Steinbeck
Journal:  Herz       Date:  1998-06       Impact factor: 1.443

8.  Recurrent atrial flutter and atrial fibrillation after catheter ablation of the cavotricuspid isthmus: a very long-term follow-up of 333 patients.

Authors:  Ming-Hsiung Hsieh; Ching-Tai Tai; Chern-En Chiang; Chin-Feng Tsai; Wen-Chung Yu; Yi-Jen Chen; Yu-An Ding; Shih-Ann Chen
Journal:  J Interv Card Electrophysiol       Date:  2002-12       Impact factor: 1.900

9.  Atrial fibrillation and its determinants after radiofrequency ablation of chronic common atrial flutter.

Authors:  Stéphane Cade; Shahine Sedighian; Agustin Bortone; Richard Gervasoni; Jean Christophe Macia; Florence Leclercq; Robert Grolleau; Jean Luc Pasquié
Journal:  Indian Pacing Electrophysiol J       Date:  2005-10-01

10.  CHA₂DS₂-VASc Score in the Prediction of Ischemic Stroke in Patients after Radiofrequency Catheter Ablation of Typical Atrial Flutter.

Authors:  Moo Nyun Jin; Changho Song; Tae Hoon Kim; Jae Sun Uhm; Hui Nam Pak; Moon Hyoung Lee; Boyoung Joung
Journal:  Yonsei Med J       Date:  2018-03       Impact factor: 2.759
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.